4d Pharma PLC - Leeds-based pharmaceutical company - Names John Doyle chief financial officer and member of the company's management team. Explains that he has over 15 years of experience in leading and developing financial operations, as well as in investor relations. Adds that he worked as chief financial officer at biopharmaceutical company Chiasma Inc before joining 4d Pharma.
"Doyle's extensive financial experience in diverse healthcare organizations and transformational events will be invaluable as 4D pharma continues to make progress in the clinic on multiple fronts with our live biotherapeutic programs," Chief Executive Duncan Peyton said.
Current stock price: 53.95 pence, up 0.7% in London on Tuesday
By Abby Amoakuh; abbyamoakuh@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
